Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of Vitamin D and Folic Acid on Mild Cognitive Impairment
Sponsor: Capital Medical University
Summary
The purpose of this study is to investigate the effects of Vitamin D3 combined with Folic Acid on mild cognitive impairment (MCI). Participants aged 50 to 70 years with MCI will be randomly assigned to three groups: a low-dose Vitamin D3 plus Folic Acid group, a high-dose Vitamin D3 plus Folic Acid group, and a placebo group. The intervention will last for 6 months. The main goal is to observe whether this nutritional intervention can improve or delay the decline of cognitive function.
Official title: Effects and Mechanisms of Vitamin D Combined With Folic Acid and Vitamin B12 on Mild Cognitive Impairment Via Regulation of Key Factors in 27-Hydroxycholesterol Metabolism
Key Details
Gender
All
Age Range
50 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
380
Start Date
2024-11-01
Completion Date
2026-06
Last Updated
2026-03-20
Healthy Volunteers
No
Conditions
Interventions
Vitamin D3 (800 IU/d) and Folic Acid(0.4mg/d)
One folic acid tablet and one low-dose Vitamin D3 tablet administered orally once daily at breakfast for 6 months.
Vitamin D3 (1600 IU/d) and Folic Acid(0.4mg/d)
One folic acid tablet and one high-dose Vitamin D3 tablet administered orally once daily at breakfast for 6 months.
Starch Placebo
Two starch placebo tablets administered orally once daily at breakfast for 6 months. The placebo is identical in appearance, color, and smell to the active tablets.
Locations (1)
Capital Medical University
Beijing, Beijing Municipality, China